← FDA DRUG APPROVALS

FDA ANDA · ANDA040701

ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE

Sponsor: BOCA PHARMA LLC

APPLICATION
ANDA040701
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-03
LATEST ACTION
2007-04-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATEDiscontinued
ACETAMINOPHEN 712.8MG, CAFFEINE 60MG, DIHYDROCODEINE BITARTRATE 32MG · TABLET · ORAL

Approval history

2007-04-03Original — Other ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →